<?xml version="1.0" encoding="UTF-8"?>
<ref id="bph15164-bib-0024">
 <mixed-citation publication-type="journal" id="bph15164-cit-0025">
  <string-name>
   <surname>Moore</surname>, 
   <given-names>H. B.</given-names>
  </string-name>, 
  <string-name>
   <surname>Barrett</surname>, 
   <given-names>C. D.</given-names>
  </string-name>, 
  <string-name>
   <surname>Moore</surname>, 
   <given-names>E. E.</given-names>
  </string-name>, 
  <string-name>
   <surname>McIntyre</surname>, 
   <given-names>R. C.</given-names>
  </string-name>, 
  <string-name>
   <surname>Moore</surname>, 
   <given-names>P. K.</given-names>
  </string-name>, 
  <string-name>
   <surname>Talmor</surname>, 
   <given-names>D. S.</given-names>
  </string-name>, … 
  <string-name>
   <surname>Yaffe</surname>, 
   <given-names>M. B.</given-names>
  </string-name> (
  <year>2020</year>). 
  <article-title>Is there a role for tissue plasminogen activator (tPA) as a novel treatment for refractory COVID‐19 associated acute respiratory distress syndrome (ARDS)?</article-title>
  <source xml:lang="en">The Journal of Trauma and Acute Care Surgery</source>, 
  <volume>88</volume>(
  <issue>1–8</issue>), 
  <fpage>713</fpage>–
  <lpage>714</lpage>. 
  <pub-id pub-id-type="doi">10.1097/TA.0000000000002694</pub-id>
  <pub-id pub-id-type="pmid">32281766</pub-id>
 </mixed-citation>
</ref>
